This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université De Limoges. Active years: 2014.
Company Filing History:
1 out of 5,383 
1 out of 55 
Years Active: 2014
Title: Micael Bardel: Innovator in Transgenic Mammal Research
Introduction
Micael Bardel is a notable inventor based in Couzeix, France. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic mammals for medical applications. His work focuses on enhancing the production of humanized antibodies, which are crucial for various therapeutic uses.
Latest Patents
Micael Bardel holds a patent titled "Non-human transgenic mammal for the constant region of the class A human immunoglobulin heavy chain and applications thereof." This invention involves a non-human transgenic mammal with an IgH locus modified by replacing the switching sequence with a transgene that includes the gene for a class A human immunoglobulin. The patent aims to facilitate the production of humanized class IgA antibodies, which have significant implications in immunology and therapeutic development. He has 1 patent to his name.
Career Highlights
Throughout his career, Micael has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Université de Limoges. His research has contributed to advancements in the understanding and application of immunoglobulin technology.
Collaborations
Micael has collaborated with notable colleagues, including Catherine Decourt and Caroline Le Morvan. These partnerships have enriched his research and expanded the impact of his innovations in the field.
Conclusion
Micael Bardel's work in transgenic mammal research exemplifies the intersection of innovation and biotechnology. His contributions are paving the way for advancements in medical therapies and antibody production.